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background:  No approach for suppressing early inflammation after MI has been reported. We recently reported that ischemic postconditioning 
with lactate-enriched blood (PCLeB) induced excellent microcirculation recovery in patients with acute MI (AHA 2012, Cardiology 2013;125:92-3). 
We therefore tested the hypothesis that PCLeB could suppress early inflammation after MI.
methods: We treated 17 consecutive patients with acute MI with primary PCI using PCLeB within 12 h of onset. In this protocol, the duration of 
each brief reperfusion was prolonged from 10 to 60 s in a stepwise manner. Lactated Ringer’s solution (20-30 mL) was injected directly into the 
culprit coronary artery at the end of each brief reperfusion, and the balloon was quickly inflated at the site of the lesion to trap the lactate within 
the ischemic myocardium. Each brief ischemic period lasted 60 s. After 7 cycles of balloon inflation and deflation, full reperfusion was performed; 
subsequently, stenting was performed. CRP was measured daily and its peak values in the first 7 days post-admission were compared with those in 
matched control patients with acute MI treated without any postconditioning procedures. In both groups, only patients with CRP values <0.3 mg/dL 
on admission were included.
results: Peak CRP values were significantly lower (P <0.01) in the PCLeB group, despite inclusion of a larger proportion of patients with proximal 
occlusion of a coronary artery in the PCLeB group.
Conclusion: PCLeB suppresses early inflammation after MI.
Control
(n = 20)
PCLeB
(n = 17)
p value
Age (y) 65.4 ± 11.1 66.6 ± 14.3 NS
Sex (m/f) 15/5 13/4 NS
Patients with diabetes mellitus (n) 5 4 NS
Time to reperfusion (h) 5.7 ± 3.1 5.8 ± 3.9 NS
Peak CK value (IU/L) 2336 ± 1143 2370 ± 1042 NS
Proximal occlusion of a coronary artery (n) 12 16 0.023
Proximal occlusion of LAD (n) 5 7 NS
Peak CRP value (mg/dL) 5.05 ± 4.85 1.66 ± 1.57 0.0091
